Coverage
-
May 23, 2011
A federal judge in California on Friday tossed a shareholder class action against XenoPort Inc., saying claims that the company withheld information about problems delaying the approval of restless legs syndrome drug Horizant weren't sufficient and needed to be redrawn.
1 other articles on this case.
View all »